Protalix BioTherapeutics
PLX
#8931
Rank
NZ$0.28 B
Marketcap
NZ$3.52
Share price
4.06%
Change (1 day)
36.11%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: NZ$0.28 Billion

As of June 2026 Protalix BioTherapeutics has a market cap of NZ$0.28 Billion. This makes Protalix BioTherapeutics the world's 8931th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 1997 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.28 B12.95%
2025NZ$0.25 B5.19%
2024NZ$0.23 B16.36%
2023NZ$0.20 B87.82%
2022NZ$0.10 B97.09%
2021NZ$55.47 M-66.92%
2020NZ$0.16 B132.08%
2019NZ$72.26 M5.04%
2018NZ$68.79 M-47.11%
2017NZ$0.13 B63.6%
2016NZ$79.51 M-46.54%
2015NZ$0.14 B-32.34%
2014NZ$0.21 B-50.33%
2013NZ$0.44 B-24.97%
2012NZ$0.58 B9.05%
2011NZ$0.54 B-48.28%
2010NZ$1.04 B41.93%
2009NZ$0.73 B206.05%
2008NZ$0.24 B-28.42%
2007NZ$0.33 B-77.03%
2006NZ$1.46 B3939.4%
2005NZ$36.25 M4336.86%
2004NZ$0.81 M-54.45%
2003NZ$1.79 M192.76%
2002NZ$0.61 M-62.05%
2001NZ$1.61 M-2.71%
2000NZ$1.65 M8.68%
1999NZ$1.52 M-85.92%
1998NZ$10.84 M-72.57%
1997NZ$39.53 M

End of Day market cap according to different sources

On Jun 11th, 2026 the market cap of Protalix BioTherapeutics was reported to be:

NZ$0.28 Billion
by Nasdaq info icon info icon
NZ$0.28 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$256.35 B 90,202.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$28.11 B 9,805.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$7.81 B 2,654.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$69.16 B 24,264.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel